Frank van Leth

Associate Professor Health Sciences

Protease inhibitors and non-nucleoside reverse transcriptase inhibitors have a comparable effect on the CD4 cell change after switching to tenofovir-based regimens.


Journal article


F. van Leth, J. Prins, J. Lange, S. Geerlings
AIDS (London), 2005

Semantic Scholar DOI PubMed
Cite

Cite

APA   Click to copy
van Leth, F., Prins, J., Lange, J., & Geerlings, S. (2005). Protease inhibitors and non-nucleoside reverse transcriptase inhibitors have a comparable effect on the CD4 cell change after switching to tenofovir-based regimens. AIDS (London).


Chicago/Turabian   Click to copy
Leth, F. van, J. Prins, J. Lange, and S. Geerlings. “Protease Inhibitors and Non-Nucleoside Reverse Transcriptase Inhibitors Have a Comparable Effect on the CD4 Cell Change after Switching to Tenofovir-Based Regimens.” AIDS (London) (2005).


MLA   Click to copy
van Leth, F., et al. “Protease Inhibitors and Non-Nucleoside Reverse Transcriptase Inhibitors Have a Comparable Effect on the CD4 Cell Change after Switching to Tenofovir-Based Regimens.” AIDS (London), 2005.


BibTeX   Click to copy

@article{f2005a,
  title = {Protease inhibitors and non-nucleoside reverse transcriptase inhibitors have a comparable effect on the CD4 cell change after switching to tenofovir-based regimens.},
  year = {2005},
  journal = {AIDS (London)},
  author = {van Leth, F. and Prins, J. and Lange, J. and Geerlings, S.}
}